Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 May 2019 | Story Xolisa Mnukwa
David Cuads
The Johannesburg High Court Judiciary Chambers donated a new wheelchair to David Phakoa Mashape from the UFS.

The Johannesburg High Court Judiciary Chambers contacted the University of the Free State (UFS) Center for Universal Access and Disability Support (CUADS), expressing their desire to donate some wheelchairs to Kovsies in need. 

David Mashape, UFS Corporate and Marketing Communication student, heard the news and did not hesitate to show his keenness to possibly receive the wheelchair. He was soon after contacted by CUADS; Free State High Court Judge, Pitso Molitsoane, personally delivered the wheelchair to David at the UFS CUADS offices in April 2019.

David explained that he had been saving up for a new wheelchair for a while, as his own was quickly wearing out.  He further mentioned that he has aspirations to play wheelchair track sports, including wheelchair racing and wheelchair rugby, and that he can now focus his savings on purchasing himself a brand-new racing wheelchair, courtesy of the generous donation from the Johannesburg High Court Judiciary Chambers. 

As stipulated in their operative mandate, CUADS strives to facilitate, create opportunities for, and enhance students’ critical thought and ways of being that are consistent with human rights and the principles of social justice. This mandate is evident in the small every-day victories, such as David’s, facilitated by the department to ensure humanising daily lived experiences essential to cultivate student academic success, social engagement, and cohesive institutional culture.



News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept